Vivos Therapeutics (VVOS) Receivables (2019 - 2026)
Vivos Therapeutics (VVOS) reported Receivables of $1.44 million for Q2 2026, down 11.9% from $1.63 million a year earlier and down 20.1% from the prior quarter.
Powered by 
Analysis
Vivos Therapeutics (VVOS) Receivables (2019 - 2026) Analysis & Trends
At the end of FY2025, Vivos Therapeutics posted Receivables of $1.6 million, up 272.1% from FY2024.
- Receivables has a five-year compound annual growth rate of 2.3% (FY2020 to FY2025).
- By year, Receivables came in at $430,000 in FY2024 (+112.9%), $202,000 in FY2023 (-55.8%), $457,000 in FY2022 (-62.0%) and $1.2 million in FY2021 (-15.9%).
- The Q2 2026 figure ranks as the lowest quarterly Receivables since Q1 2025.
- Year over year, Receivables gained in seven of the last eight quarters, with growth averaging 167.3%.
- The high point for year-over-year Receivables in five years was Q3 2025 (growth of 370.0%); the low point was Q3 2022 (a decline of 77.4%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.8 million (Q1 2026), $1.58 million (Q4 2025) and $2.13 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 252.90 Bn | 231.92 Bn | 4.88 Bn | 11.14 Bn |
| 2 | Abbott Laboratories | 180.49 Bn | 150.92 Bn | 7.27 Bn | 8.60 Bn |
| 3 | Danaher | 158.97 Bn | 142.78 Bn | 3.61 Bn | 3.97 Bn |
| 4 | Intuitive Surgical | 153.68 Bn | 133.11 Bn | 1.96 Bn | 1.67 Bn |
| 5 | Medtronic | 120.44 Bn | 85.69 Bn | 6.34 Bn | 6.36 Bn |
| 6 | Stryker | 115.51 Bn | 101.62 Bn | 4.50 Bn | 3.74 Bn |
| 7 | Boston Scientific | 67.38 Bn | 62.15 Bn | 3.85 Bn | 3.05 Bn |
| 8 | Becton Dickinson | 52.94 Bn | 50.09 Bn | 2.32 Bn | 2.36 Bn |
| 9 | Edwards Lifesciences | 50.65 Bn | 34.65 Bn | 1.35 Bn | 955.70 Mn |
| 10 | Vivos Therapeutics | 2.30 Mn | -6.74 Mn | 2.95 Mn | 1.44 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.44 Mn |
| Mar 31, 2026 | 1.80 Mn |
| Dec 31, 2025 | 1.58 Mn |
| Sep 30, 2025 | 2.13 Mn |
| Jun 30, 2025 | 1.63 Mn |
| Mar 31, 2025 | 718,000.00 |
| Dec 31, 2024 | 430,000.00 |
| Sep 30, 2024 | 454,000.00 |
| Jun 30, 2024 | 395,000.00 |
| Mar 31, 2024 | 525,000.00 |
| Dec 31, 2023 | 202,000.00 |
| Sep 30, 2023 | 228,000.00 |
| Jun 30, 2023 | 327,000.00 |
| Mar 31, 2023 | 321,000.00 |
| Dec 31, 2022 | 457,000.00 |
| Sep 30, 2022 | 866,000.00 |
| Jun 30, 2022 | 791,000.00 |
| Mar 31, 2022 | 1.00 Mn |
| Dec 31, 2021 | 1.20 Mn |
| Sep 30, 2021 | 3.83 Mn |
API Access
Vivos Therapeutics Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=VVOS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "VVOS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=VVOS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();